Healthcare Global [HCG] vs Apollo Hospitals [APOLLOHOSP] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Healthcare Global Enterprises Ltd. wins in 6 metrics, Apollo Hospitals Enterprise Ltd. wins in 13 metrics, with 0 ties. Apollo Hospitals Enterprise Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Healthcare Global Enterprises Ltd. | Apollo Hospitals Enterprise Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 438.11 | 61.08 | Apollo Hospitals Enterprise Ltd. |
| Price-to-Book Ratio | 8.81 | 12.11 | Healthcare Global Enterprises Ltd. |
| Debt-to-Equity Ratio | 177.91 | 83.61 | Apollo Hospitals Enterprise Ltd. |
| PEG Ratio | -1.86 | 1.87 | Apollo Hospitals Enterprise Ltd. |
| EV/EBITDA | 26.72 | 35.93 | Healthcare Global Enterprises Ltd. |
| Profit Margin (TTM) | 0.77% | 7.44% | Apollo Hospitals Enterprise Ltd. |
| Operating Margin (TTM) | 7.73% | 11.52% | Apollo Hospitals Enterprise Ltd. |
| EBITDA Margin (TTM) | 7.73% | 11.52% | Apollo Hospitals Enterprise Ltd. |
| Return on Equity | 4.49% | 16.71% | Apollo Hospitals Enterprise Ltd. |
| Return on Assets (TTM) | 1.25% | 7.00% | Apollo Hospitals Enterprise Ltd. |
| Free Cash Flow (TTM) | $1.08B | $4.24B | Apollo Hospitals Enterprise Ltd. |
| Dividend Yield | N/A | 0.26% | N/A |
| 1-Year Return | 17.49% | 18.84% | Apollo Hospitals Enterprise Ltd. |
| Price-to-Sales Ratio (TTM) | 3.48 | 4.55 | Healthcare Global Enterprises Ltd. |
| Enterprise Value | $96.59B | $1,154.53B | Apollo Hospitals Enterprise Ltd. |
| EV/Revenue Ratio | 3.90 | 4.77 | Healthcare Global Enterprises Ltd. |
| Gross Profit Margin (TTM) | 49.98% | 47.78% | Healthcare Global Enterprises Ltd. |
| Revenue per Share (TTM) | $176 | $1,684 | Apollo Hospitals Enterprise Ltd. |
| Earnings per Share (Diluted) | $1.32 | $125.45 | Apollo Hospitals Enterprise Ltd. |
| Beta (Stock Volatility) | -0.24 | 0.18 | Healthcare Global Enterprises Ltd. |
Healthcare Global Enterprises Ltd. vs Apollo Hospitals Enterprise Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Healthcare Global Enterprises Ltd. | 0.49% | -3.71% | 4.26% | 12.80% | -13.26% | -3.24% |
| Apollo Hospitals Enterprise Ltd. | 2.48% | -2.05% | 4.55% | 3.82% | 11.70% | 13.75% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Healthcare Global Enterprises Ltd. | 17.49% | 100.58% | 242.33% | 253.93% | 263.93% | 263.93% |
| Apollo Hospitals Enterprise Ltd. | 18.84% | 64.61% | 141.90% | 498.35% | 1,591.63% | 3,846.19% |
Performance & Financial Health Analysis: Healthcare Global Enterprises Ltd. vs Apollo Hospitals Enterprise Ltd.
| Metric | HCG | APOLLOHOSP |
|---|---|---|
| Market Information | ||
| Market Cap | ₹85.12B | ₹1.12T |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 156,294 | 402,584 |
| 90 Day Avg. Volume | 214,217 | 434,868 |
| Last Close | ₹634.75 | ₹8,290.50 |
| 52 Week Range | ₹513.30 - ₹804.65 | ₹6,696.50 - ₹8,443.00 |
| % from 52W High | -21.11% | -1.81% |
| All-Time High | ₹804.65 (Oct 24, 2025) | ₹552,030.00 (Nov 20, 2023) |
| % from All-Time High | -21.11% | -98.50% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.17% |
| Quarterly Earnings Growth | 0.13% | 0.35% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.07% |
| Operating Margin (TTM) | 0.08% | 0.12% |
| Return on Equity (TTM) | 0.04% | 0.17% |
| Debt to Equity (MRQ) | 177.91 | 83.61 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹65.64 | ₹632.45 |
| Cash per Share (MRQ) | ₹14.54 | ₹218.70 |
| Operating Cash Flow (TTM) | ₹824.28M | ₹14.57B |
| Levered Free Cash Flow (TTM) | ₹444.10M | ₹14.46B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.26% |
| Last 12-Month Dividend | N/A | ₹20.00 |
Valuation & Enterprise Metrics Analysis: Healthcare Global Enterprises Ltd. vs Apollo Hospitals Enterprise Ltd.
| Metric | HCG (Apr 23, 2026) | APOLLOHOSP (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 438.11 | 61.08 |
| Forward P/E | 61.80 | 46.07 |
| PEG Ratio | -1.86 | 1.87 |
| Price to Sales (TTM) | 3.48 | 4.55 |
| Price to Book (MRQ) | 8.81 | 12.11 |
| Market Capitalization | ||
| Market Capitalization | ₹85.12B | ₹1.12T |
| Enterprise Value | ₹96.59B | ₹1.15T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.90 | 4.77 |
| Enterprise to EBITDA | 26.72 | 35.93 |
| Risk & Other Metrics | ||
| Beta | -0.24 | 0.18 |
| Book Value per Share (MRQ) | ₹65.64 | ₹632.45 |
Financial Statements Comparison: Healthcare Global Enterprises Ltd. vs Apollo Hospitals Enterprise Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | HCG (2025) | APOLLOHOSP (2025) |
|---|---|---|
| Revenue/Sales | 22.01B | 215.77B |
| Cost of Goods Sold | 10.84B | 113.10B |
| COGS % of Revenue | 49.2% | 52.4% |
| Gross Profit | 11.17B | 102.67B |
| Gross Margin | 50.8% | 47.6% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 1.87B | 22.76B |
| Operating Margin | 8.5% | 10.5% |
| EBITDA | 4.22B | 31.48B |
| EBITDA Margin | 19.2% | 14.6% |
| Pre-Tax Income | 569.64M | 20.39B |
| Pre-Tax Income % of Revenue | 2.6% | 9.5% |
| Income Tax | 81.30M | 5.34B |
| Income Tax % of Revenue | 0.4% | 2.5% |
| Net Income (Profit) | 488.34M | 15.05B |
| Profit Margin | 2.2% | 7.0% |
Balance Sheet & Liquidity Metrics
| Metric | HCG (2025) | APOLLOHOSP (2025) |
|---|---|---|
| Cash & Equivalents | 2.36B | 5.78B |
| Total Current Assets | 8.44B | 70.29B |
| Total Current Assets % of Revenue | 38.3% | 32.6% |
| Total Current Liabilities | 10.46B | 45.79B |
| Total Current Liabilities % of Revenue | 47.5% | 21.2% |
| Long-Term Debt | 13.80B | 43.86B |
| Long-Term Debt % of Revenue | 62.7% | 20.3% |
| Total Shareholders Equity | 9.90B | 86.53B |
| Retained Earnings | -4.09B | 39.41B |
| Retained Earnings % of Revenue | -18.6% | 18.3% |
| Property, Plant & Equipment | 934.71M | 39.33B |
Cash Flow Statement Comparison
| Metric | HCG (2025) | APOLLOHOSP (2025) |
|---|---|---|
| Operating Cash Flow | 824.28M | 14.57B |
| Operating Cash Flow % of Revenue | 3.7% | 6.8% |
| Capital Expenditures | -2.07B | -16.98B |
| Free Cash Flow | 1.08B | 4.24B |
| FCF Margin | 4.9% | 2.0% |
| Debt Repayment | -817.59M | -4.42B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HCG | APOLLOHOSP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 149.30M | 143.78M |
| Float Shares | 55.09M | 100.66M |
| % Held by Insiders | 66.66% | 28.02% |
| % Held by Institutions | 16.16% | 47.21% |
| % Held by Public | 17.18% | 24.77% |
Dividend Analysis & Yield Comparison: Healthcare Global Enterprises Ltd. vs Apollo Hospitals Enterprise Ltd.
| Metric | HCG | APOLLOHOSP |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹20.00 |
| Last 12-Month Dividend Yield | N/A | 0.26% |
| 3-Year Avg Annual Dividend | N/A | ₹23.00 |
| 3-Year Avg Dividend Yield | N/A | 0.14% |
| 3-Year Total Dividends | N/A | ₹69.00 |
| Ex-Dividend Date | N/A | Feb 16, 2026 |